The International Accreditation System for Interventional Oncology Services (IASIOS) has announced the enrolment of its first paediatric centre, St. Jude Children’s Research Hospital in Memphis, USA.
A recent press release by IASIOS has stated that, as the first paediatric hospital to seek IASIOS accreditation, St. Jude is setting a new precedent in paediatric oncology and establishing a benchmark within the broader field of interventional oncology (IO), pushing the boundaries of cancer care for children.
IASIOS offers healthcare institutions a framework to standardise patient pathways and implement measurable quality standards. As IO becomes recognised as the fourth pillar of cancer treatment, alongside surgery, radiation, and systemic therapies, it is essential for hospitals providing IO services to adhere to rigorous guidelines to guarantee safe and effective treatments.
The IASIOS standards are based on the Cardiovascular and Interventional Radiological Society of Europe’s (CIRSE) Quality Assurance Guidelines for Interventional Oncology, endorsed by the European Cancer Organisation (ECO) and supported by over 40 international medical societies.
Michael Temple, director of interventional radiology in the diagnostic imaging department at St. Jude, leads the accreditation effort: “At St. Jude, we are focused on the development, assessment and promotion of paediatric interventional oncology procedures. Seeking IASIOS accreditation demonstrates to our young patients and their families, our commitment to providing the highest quality of clinical care.”
As an IASIOS enrolled centre, St. Jude joins a global community of IO centres dedicated to advancing and promoting IO practices. This international network allows member facilities to collaborate, share knowledge, and participate in exclusive events, seminars, and workshops, all while working to raise awareness about the benefits of IO among patients and medical providers.
